IPO Calendar
Lead Manager
- J P Morgan Chase (515)
- Goldman Sachs (492)
- Morgan Stanley (445)
- Bank of America Merrill Lynch (374)
- Citigroup (236)
- Jefferies (223)
- Credit Suisse (180)
- Barclays (158)
- Cowen and Company (147)
- Deutsche Bank (85)
- Leerink Partners (73)
- Piper Jaffray (70)
- Stifel (67)
- UBS Investment Bank (56)
- Evercore (55)
- RBC Capital (53)
- BMO Capital (52)
- Wells Fargo (48)
- Piper Sandler (43)
- Revere Securities (42)
More +
IPO - Pricing (10)
BMO Capital
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 26 | Gamida Cell Ltd | Health-Care | 8 | 6 | BMO | RBC | 16.8% | 5.5% | |||
| Sep 26 | Entasis Therape | Health-Care | 15 | 5 | BMO | CS | 48.2% | -28.9% | |||
| Jul 26 | Berry Petroleum | Energy | 14 | 13 | BMO | GS | WLFG | 38.8% | -5.4% | ||
| Jul 25 | Aquestive Thera | Health-Care | 15 | 4 | BMO | RBC | 69.8% | 7% | |||
| Jul 20 | Replimune Group | Health-Care | 15 | 6 | BMO | JPM | LRNK | 46.6% | 1.1% | ||
| Jun 21 | Aptinyx Inc. | Health-Care | 16 | 6 | BMO | COWN | JPM | 54.8% | 26.3% | ||
| May 24 | Scholar Rock Ho | Health-Care | 14 | 5 | BMO | COWN | JEFF | 34.8% | 10.7% | ||
| May 9 | Evelo Bioscienc | Health-Care | 16 | 5 | BMO | COWN | MS | 38% | 1.6% | ||
| Mar 8 | BioXcel Therape | Health-Care | 11 | 59 | BRCL | BMO | UBS | 3.2% | 0.3% | ||
| Feb 1 | Sol-Gel Technol | Health-Care | 12 | 6 | JEFF | BMO | 39% | 13.7% | |||
*
Lead manager or one of top three managers in an underwriting team.